PPH vs. SGVT
PPH (VanEck Pharmaceutical ETF) and SGVT (Schwab Government Money Market ETF) are both exchange-traded funds - PPH is a Health & Biotech Equities fund tracking the MVIS US Listed Pharmaceutical 25 Index, while SGVT is a Money Market fund actively managed by Charles Schwab. PPH is passively managed, while SGVT is actively managed. Over the past year, PPH returned 18.69% vs 3.74% for SGVT. At a 0.05 correlation, their price movements are largely independent. PPH charges 0.36%/yr vs 0.28%/yr for SGVT.
Performance
PPH vs. SGVT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PPH achieves a 2.96% return, which is significantly higher than SGVT's 1.51% return.
PPH
- 1D
- -1.04%
- 1M
- 4.48%
- YTD
- 2.96%
- 6M
- 3.80%
- 1Y
- 18.69%
- 3Y*
- 12.38%
- 5Y*
- 9.47%
- 10Y*
- 8.39%
SGVT
- 1D
- -0.01%
- 1M
- 0.26%
- YTD
- 1.51%
- 6M
- 1.68%
- 1Y
- 3.74%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PPH vs. SGVT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
PPH VanEck Pharmaceutical ETF | 2.96% | 15.74% |
SGVT Schwab Government Money Market ETF | 1.51% | 2.22% |
Correlation
The correlation between PPH and SGVT is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (All Time) Calculated using the full available price history since Jun 12, 2025 | 0.05 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PPH vs. SGVT — Risk / Return Rank
PPH
SGVT
PPH vs. SGVT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Pharmaceutical ETF (PPH) and Schwab Government Money Market ETF (SGVT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PPH | SGVT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -17.26 | ||
| Sortino ratioReturn per unit of downside risk | -99.21 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 36.10 | -34.91 |
| Calmar ratioReturn relative to maximum drawdown | 1.74 | 138.97 | -137.23 |
| Martin ratioReturn relative to average drawdown | 4.30 | 1,477.41 | -1,473.12 |
Loading charts...
Drawdowns
PPH vs. SGVT - Drawdown Comparison
The maximum PPH drawdown since its inception was -51.45%, which is greater than SGVT's maximum drawdown of -0.03%. Use the drawdown chart below to compare losses from any high point for PPH and SGVT.
Loading charts...
Drawdown Indicators
| PPH | SGVT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -51.45% | -0.03% | -51.42% |
Max Drawdown (1Y)Largest decline over 1 year | -10.76% | -0.03% | -10.73% |
Max Drawdown (3Y)Largest decline over 3 years | -18.06% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -20.26% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -29.70% | — | — |
Current DrawdownCurrent decline from peak | -4.90% | -0.01% | -4.89% |
Average DrawdownAverage peak-to-trough decline | -17.29% | -0.00% | -17.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.45% | 0.00% | +4.45% |
Volatility
PPH vs. SGVT - Volatility Comparison
VanEck Pharmaceutical ETF (PPH) has a higher volatility of 5.95% compared to Schwab Government Money Market ETF (SGVT) at 0.07%. This indicates that PPH's price experiences larger fluctuations and is considered to be riskier than SGVT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PPH | SGVT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.95% | 0.07% | +5.88% |
Volatility (6M)Calculated over the trailing 6-month period | 12.18% | 0.13% | +12.05% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.66% | 0.21% | +17.45% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.14% | 0.21% | +14.93% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.00% | 0.21% | +16.79% |
PPH vs. SGVT - Expense Ratio Comparison
PPH has a 0.36% expense ratio, which is higher than SGVT's 0.28% expense ratio.
Dividends
PPH vs. SGVT - Dividend Comparison
PPH's dividend yield for the trailing twelve months is around 2.05%, less than SGVT's 3.12% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PPH VanEck Pharmaceutical ETF | 2.05% | 1.78% | 1.98% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% |
SGVT Schwab Government Money Market ETF | 3.12% | 1.73% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
PPH and SGVT have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PPH has higher volatility (5.95%) compared to SGVT (0.07%). In terms of maximum drawdown, PPH dropped -51.45% vs SGVT's -0.03%.
On 1-year performance, PPH leads with 18.69% vs 3.74% for SGVT. On fees, SGVT is cheaper at 0.28% per year. On volatility, SGVT has been the lower-risk option at 0.07%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, PPH has performed better with a 18.69% return vs 3.74%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SGVT is cheaper with a 0.28% expense ratio, compared with 0.36% for PPH.
SGVT has the higher dividend yield at 3.12%, compared with 2.05% for PPH.
PPH is categorized as Health & Biotech Equities, while SGVT is Money Market. They also come from different issuers: VanEck and Charles Schwab. Their fees differ too: 0.36% for PPH and 0.28% for SGVT.
SGVT currently has the higher Sharpe Ratio (18.33 vs 1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PPH and SGVT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer